Download or read book Canadian Prescription Drug Importation written by United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness and published by . This book was released on 2003 with total page 156 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Examining Prescription Drug Importation written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and published by . This book was released on 2002 with total page 120 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Importation of Prescription Drugs written by United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions and published by . This book was released on 2005 with total page 132 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book CANADIAN PRESCRIPTION DRUG IMPORTATION IS HEARING SERIAL NO 108 59 COMMITTEE ON GOVERNMENT U S HOUSE OF REPRESENTATIVES 10 written by and published by . This book was released on 2004* with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Canadian Prescription Drug Importation Is There a Safety Issue June 12 2003 written by United States. Congress. House. Committee on Government Reform and published by . This book was released on 2003* with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Canadian Prescription Drug Importation written by United States. Congress and published by Createspace Independent Publishing Platform. This book was released on 2018-02-18 with total page 148 pages. Available in PDF, EPUB and Kindle. Book excerpt: Canadian prescription drug importation : is there a safety issue? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 12 2003.
Download or read book Drug Importation written by United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions and published by . This book was released on 2005 with total page 68 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book 108 1 Hearing Canadian Prescription Drug Importation Is There a Safety Issue June 12 2003 written by and published by . This book was released on 2003* with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Internet Pharmacy and Drug Importation written by United States. Congress. Senate. Special Committee on Aging and published by . This book was released on 2005 with total page 80 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book S 334 written by United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions and published by . This book was released on 2005 with total page 78 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Examining the Implications of Drug Importation written by United States. Congress. Senate. Committee on the Judiciary and published by . This book was released on 2008 with total page 294 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Options for Safe and Effective Prescription Drug Importation written by United States. Congress. Senate. Committee on Commerce, Science, and Transportation and published by . This book was released on 2012 with total page 68 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Canadian Prescription Drug Importation written by United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness and published by . This book was released on 2003 with total page 150 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Importation of Prescription Drugs Provisions in P L 108 173 the Medicare Prescription Drug Improvement and Modernization Act of 2003 written by and published by . This book was released on 2004 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The new Medicare legislation, the Medicare Prescription Drug, Improvement, and Modernization Act (P.L. 108-173), addresses the importation of prescription drugs for all U .S. consumers, not just for Medicare-eligible individuals. These provisions are rooted in consumer and congressional concern with the high cost of prescription drugs in the United States. International comparisons of drug prices have confirmed that American consumers, particularly the elderly and uninsured, often pay more for prescription drugs than do citizens in other countries. The importation of lower-priced prescription drugs is one strategy to reduce U.S. consumer spending. The new Act, despite being structured as a replacement to the importation provisions in the Medicine Equity and Drug Safety (MEDS) Act of 2000, does not effectively change U.S. prescription drug importation policy. The details it adds will not be implemented unless the Secretary of Health and Human Services (hereafter referred to as the Secretary) certifies to Congress that such imports do not threaten the health and safety of the American public and do provide cost savings. That certification requirement, continued from prior law, has effectively halted implementation of existing import provisions because no Secretary has been willing to provide the required certification. The Act changes the law in four basic ways: it (1) directs the Secretary to allow imports from Canada only (the MEDS Act had allowed imports from a specific list of industrialized countries, including Canada); (2) includes a shift in approach to the importation of prescription drugs by individuals, by codifying the discretion in enforcement that the Food and Drug Administration (FDA) has exercised to allow the "personal use" imports of prescription drugs; (3) eliminates the prohibition against a manufacturer's entering into agreements to prevent the sale or distribution of imported products; and (4) includes a mechanism, based on evidence, by which the Secretary can terminate the import program. Following enactment of the Medicare bill in December 2003, some Members of Congress have moved to amend the importation of prescription drugs provisions. Some states and localities have set up websites to facilitate individuals' purchase of prescription drugs from Canadian pharmacies. FDA has responded. In letters to state officials, FDA has warned that states could face tort liability suits and charges of assisting in criminal activity if citizens suffer injury from these drugs. FDA, via the Department of Justice, has gone to the courts to stop the Canadian and U.S. distributors of drugs imported from Canada.
Download or read book Importing Prescription Drugs written by and published by . This book was released on 2002 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: In recent years, American consumers, particularly the elderly and uninsured, have discovered they often pay a lot more for pharmaceuticals than citizens in other countries. As prescription drug prices continue to rise, more patients are turning to the Internet, or traveling outside the county, to find cheaper prescription drugs. Under current law, however, only drug companies can import pharmaceuticals into the United States. Despite this legal restriction, the Food and Drug Administration (FDA) has for years allowed patients to bring a 90-day supply of prescription medications into the country under its so-called "personal use" import policy. In 2000, the 106th Congress passed the Medicine Equity and Drug Safety (MEDS) Act, legislation that would have allowed pharmacists and drug wholesalers to import less costly FDA-approved drugs from other countries. However, Congress stipulated that the Act could not be implemented unless the Secretary of Health and Human Services (HHS) could first guarantee that all drugs imported under the program would be safe and offer significant cost savings for consumers. In time, both the former and current Secretaries said these conditions could not be met, and declined to implement the law. Congress is considering several ways to increase the supply of less costly prescription drugs for consumers, in particular codifying FDA's "personal use" import policy, and creating a program that would let pharmacists and drug wholesalers import drugs commercially. On July 31, 2002, the Senate passed the Greater Access to Affordable Pharmaceuticals Act (S. 812), legislation to speed-up the approval of less costly generic drugs. The bill included the text of the Prescription Drug Price Parity for Americans Act (S. 2244), an amendment offered by Senator Dorgan, that would allow people to bring a 90-day supply of prescription drugs into the country for personal use from registered Canadian pharmacies, and simultaneously create a commercial import program, similar to the MEDS Act, that would let licensed pharmacists and drug wholesalers import FDA-approved prescription drugs from Canada. The Senate also agreed to an amendment sponsored by Senator Cochran that would require the Secretary of HHS to first certify to Congress that all imported drugs would be safe and offer significant cost savings for consumers, the same two contingencies that kept the MEDS Act from being implemented in 2000. H.R. 4614, a bill similar to the Dorgan amendment is currently pending in the House. Supporters of the various drug import proposals are urging Congress to pass legislation that will codify FDA's personal use import policy, making it easier for patients to bring cheaper prescription drugs into the country, and at the same time establish a program allowing pharmacists and drug wholesalers to import drugs commercially from Canada. Opponents, on the other hand, argue that these proposals could weaken existing import laws and make it easier for unsafe or counterfeit drugs to enter the country. While the Dorgan/Sanders bills would mandate authenticity testing to safeguard against this, the cost of testing would likely be passed on to consumers, and critics question whether there would be a noticeable reduction in the price of prescription drugs.
Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Download or read book International Prescription Drug Parity written by United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness and published by . This book was released on 2003 with total page 160 pages. Available in PDF, EPUB and Kindle. Book excerpt:
